Health Information
Health Education
Health EducationMedication Guidance-K-Citrate 用藥指導-K-Citrate(結石清)
2024/1/22Usually, adults can take it three or four times a day after meals or before bed. The doctor will adjust the dosage according to your urine analysis and evaluation.
Medication Guidance-Differin 用藥指導-Differin(痘膚潤)
2024/1/22Apply it once a day to the affected part of the acne. Apply a layer of gel film and carefully avoid the eyes, lips and nose corner.
Medication Guidance-Anti-inflammatory Throat Spray 用藥指導-口腔消炎噴液劑
2024/1/22Adults (>12 years): Directly spray it 2-4 times on sore and swollen areas before slowly swallowing. Children aged 6-12 years: Directly spray it twice over sore and swollen areas before slowly swallowing. It can be reused every 1.5 to 3 hours if necessary.
Medication Guidance-Xenical Capsules 用藥指導-Xenical(羅鮮子)膠囊
2024/1/22It is recommended that one capsule be taken orally during the main meal or within 1 hour at the latest after the meal.
Medication Guidance-Metered-dose, Dry Powder Inhaler Accuhaler 用藥指導-定量粉狀吸入劑Accuhaler(胖胖魚)
2024/1/22The use of the metered-dose, dry powder inhaler Accuhaler is completely controlled by the patient's breathing.
Patient Safety: General Medication Safety Instructions 病人安全 一般用藥安全須知
2024/1/22Allergic or abnormal reactions to medicines, foods or special substances.
Medication Instruction- Oral Antiviral Drug(Molnupiravir) for COVID-19 用藥指導-COVID-19治療口服抗病毒藥品Molnupiravir
2024/1/22Applicant: To be prescribed to adult patients with mild-to-moderate COVID-19 at high risk of severe disease, aged 18 years of age and older, have not used oxygen therapy and have onset within 5 days. For patients who could not use other recommended drugs.
Medication Guidance- Oral Antiviral Paxlovid Drug for COVID-19 用藥指導-COVID-19治療口服抗病毒藥品Paxlovid
2024/1/22Applicant: To be prescribed to adult patients and children patients (aged at least 12 years and weigh at least 40 KG) with mild-to-moderate COVID-19 at high risk of severe disease, and have onset within 5 days.
Idarubicin 認識化療藥品 Idarubicin
2024/1/22Idarubicin is classified as an anthracyline antibiotic. This medicine inhibits DNA synthesis by producing DNA cross-links which halt cell replication and eventually cause cell death. This cell damage slows or stops the growth of cancer cells in the body.
Asparaginase 認識化療藥品Asparaginase
2024/1/22Asparaginase is an enzyme that breaks down asparagine in the body.